609-23-4
609-23-4
Chemical Structure
2,4,6-Triiodophenol
- CAS No.: 609-23-4
- Formula:C6H3I3O
- Molecular Weight:471.80
IUPAC Name: 2,4,6-triiodophenol
InChIKey: VAPDZNUFNKUROY-UHFFFAOYSA-N
SMILES: OC1=C(I)C=C(I)C=C1I
Biological Activity: 2,4,6-Triiodophenol is an orally active and potent leukotriene B4 (LTB4) synthesis inhibitor. 2,4,6-Triiodophenol can induce mouse blastocysts apoptosis[1][2].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2,4,6-Triiodophenol | 98.0% | 2,4,6-Triiodophenol is an orally active and potent leukotriene B4 (LTB4) synthesis inhibitor. 2,4,6-Triiodophenol can induce mouse blastocysts apoptosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Riodoxol | 97.02% | Riodoxol is an antiviral agent. Riodoxol affects multiplication and maturation of the virus. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ioxynil | 98.0% | Ioxynil is an herbicide that act as endocrine disruptor. Ioxynil can disrupt vascular and heart development in zebrafish. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,5-Dichlorocatechol | 98.07% | 3,5-Dichlorocatechol is a substrate of the broad-spectrum chlorocatechol 1,2-dioxygenase of pseudomonas chlororaphis RW71. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
HTBA | 99.67% | HTBA (3-Hydroxy-2,4,6-triiodobenzoic acid) is a biochemical reagent and important intermediate. HTBA can be used in the research of life science, organic chemistry and other fields. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
1,3,5-Triiodo-2-methoxybenzene | 99.86% | 1,3,5-Triiodo-2-methoxybenzene is a drug intermediate for synthesis of various active compounds. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Diiodohydroxyquinoline | 98.0% | Diiodohydroxyquinoline (Iodoquinol, 5,7-Diiodo-8-hydroxyquinoline, 5,7-Diiodo-8-quinolinol) has an orally active and satisfactory antiparasitic properties. Diiodohydroxyquinoline exhibits mutagenic potential in mice and potent anti-SARS-CoV-2 activity with an EC50 value of 1.38 μM in VeroE6 cells. Diiodohydroxyquinoline's antimutagen is ascorbic acid. Diiodohydroxyquinoline is promising for research in inflammationin, testinal amebiasis, amebic liver abscess and chronic nonspecific diarrheas. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2,6-Dimethylhydroquinone (Standard) | ≥98% | 2,6-Dimethylhydroquinone (Standard) is an analytical standard for 2,6-Dimethylhydroquinone (HY-W004874). This product is intended for research and analytical applications. 2,6-Dimethylhydroquinone is a key metabolic intermediate in the degradation of 2,6-xylenol by Mycobacterium strain DM1. 2,6-Dimethylhydroquinone can be used as an early indicator of failure in biological treatment systems. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
m-Iodophenol | 99.89% | m-Iodophenol is a protaetia brevitarsis attractant. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,5-Diiodo-4-hydroxybenzoic acid | 99.97% | 3,5‑Diiodo‑4‑hydroxybenzoic acid (DIHB) is a plant growth regulator that alleviates the inhibition of plant root elongation under various stress conditions. 3,5-Diiodo-4-hydroxybenzoic acid promotes root elongation under conditions of adequate oxygen supply, absence of stress, and no mechanical impedance, increases the effective cell wall extensibility factor, and promotes root/stem growth in plants in compacted or loose soil; it exhibits lower activity under oxygen stress. 3,5-Diiodo-4-hydroxybenzoic acid can be used in research related to plant growth regulation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
1,4-Dibromo-2,5-diiodobenzene | 98.15% | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Liu S, et al. 2,4,6-triiodophenol exhibits embryotoxicity to pre-implantation mouse embryos in an in vitro exposure model. Ecotoxicol Environ Saf. 2022 Aug;241:113745. [Content Brief]
- [2]. Trocóniz IF, et al. Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B4 synthesis inhibitor. Pharm Res. 2006 Jul;23(7):1533-42. [Content Brief]
